vs
KALTURA INC（KLTR）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是KALTURA INC的1.7倍（$75.5M vs $45.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -0.1%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $3.5M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 0.8%）
Kaltura Inc是2006年成立、总部位于纽约的软件企业，业务覆盖多个核心领域：网络研讨会与虚拟活动、企业视频内容管理、在线视频平台、教育科技以及云电视软件，可提供视频门户、学习管理系统与内容管理系统扩展插件、虚拟活动与网络研讨会平台、电视流媒体应用等多款产品。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
KLTR vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.7倍
$45.5M
营收增速更快
PBYI
高出27.9%
-0.1%
自由现金流更多
PBYI
多$10.9M
$3.5M
两年增速更快
PBYI
近两年复合增速
0.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.5M | $75.5M |
| 净利润 | $-575.0K | — |
| 毛利率 | 72.4% | 69.3% |
| 营业利润率 | 1.9% | 22.7% |
| 净利率 | -1.3% | — |
| 营收同比 | -0.1% | 27.7% |
| 净利润同比 | 91.3% | — |
| 每股收益（稀释后） | — | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KLTRPBYI
| Q4 25 | $45.5M | $75.5M | ||
| Q3 25 | $43.9M | $54.5M | ||
| Q2 25 | $44.5M | $52.4M | ||
| Q1 25 | $47.0M | $46.0M | ||
| Q4 24 | $45.6M | $59.1M | ||
| Q3 24 | $44.3M | $80.5M | ||
| Q2 24 | $44.0M | $47.1M | ||
| Q1 24 | $44.8M | $43.8M |
净利润KLTRPBYI
| Q4 25 | $-575.0K | — | ||
| Q3 25 | $-2.6M | $8.8M | ||
| Q2 25 | $-7.8M | $5.9M | ||
| Q1 25 | $-1.1M | $3.0M | ||
| Q4 24 | $-6.6M | — | ||
| Q3 24 | $-3.6M | $20.3M | ||
| Q2 24 | $-10.0M | $-4.5M | ||
| Q1 24 | $-11.1M | $-4.8M |
毛利率KLTRPBYI
| Q4 25 | 72.4% | 69.3% | ||
| Q3 25 | 70.0% | 77.7% | ||
| Q2 25 | 70.2% | 76.5% | ||
| Q1 25 | 69.7% | 77.1% | ||
| Q4 24 | 70.8% | 76.4% | ||
| Q3 24 | 66.7% | 63.9% | ||
| Q2 24 | 65.1% | 77.4% | ||
| Q1 24 | 63.9% | 75.5% |
营业利润率KLTRPBYI
| Q4 25 | 1.9% | 22.7% | ||
| Q3 25 | -3.4% | 17.6% | ||
| Q2 25 | -6.2% | 12.7% | ||
| Q1 25 | -3.4% | 8.7% | ||
| Q4 24 | -8.3% | 22.6% | ||
| Q3 24 | -10.1% | 27.4% | ||
| Q2 24 | -19.4% | -4.6% | ||
| Q1 24 | -16.3% | -5.3% |
净利率KLTRPBYI
| Q4 25 | -1.3% | — | ||
| Q3 25 | -6.0% | 16.2% | ||
| Q2 25 | -17.4% | 11.2% | ||
| Q1 25 | -2.4% | 6.5% | ||
| Q4 24 | -14.5% | — | ||
| Q3 24 | -8.1% | 25.2% | ||
| Q2 24 | -22.7% | -9.6% | ||
| Q1 24 | -24.8% | -11.0% |
每股收益（稀释后）KLTRPBYI
| Q4 25 | — | $0.26 | ||
| Q3 25 | $0.02 | $0.17 | ||
| Q2 25 | $-0.05 | $0.12 | ||
| Q1 25 | — | $0.06 | ||
| Q4 24 | — | $0.40 | ||
| Q3 24 | $0.02 | $0.41 | ||
| Q2 24 | $-0.07 | $-0.09 | ||
| Q1 24 | — | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $51.9M | $97.5M |
| 总债务越低越好 | $29.3M | $22.7M |
| 股东权益账面价值 | $6.3M | $130.3M |
| 总资产 | $164.7M | $216.3M |
| 负债/权益比越低杠杆越低 | 4.63× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资KLTRPBYI
| Q4 25 | $51.9M | $97.5M | ||
| Q3 25 | $72.2M | $94.4M | ||
| Q2 25 | $71.2M | $96.0M | ||
| Q1 25 | $62.9M | $93.2M | ||
| Q4 24 | $81.3M | $101.0M | ||
| Q3 24 | $77.7M | $96.7M | ||
| Q2 24 | $68.3M | $96.8M | ||
| Q1 24 | $68.9M | $107.2M |
总债务KLTRPBYI
| Q4 25 | $29.3M | $22.7M | ||
| Q3 25 | $30.6M | $34.0M | ||
| Q2 25 | $31.3M | $45.3M | ||
| Q1 25 | $31.9M | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | $33.3M | $79.3M | ||
| Q2 24 | $33.7M | $90.7M | ||
| Q1 24 | $34.1M | $102.0M |
股东权益KLTRPBYI
| Q4 25 | $6.3M | $130.3M | ||
| Q3 25 | $17.7M | $115.3M | ||
| Q2 25 | $17.0M | $104.7M | ||
| Q1 25 | $22.7M | $97.1M | ||
| Q4 24 | $24.4M | $92.1M | ||
| Q3 24 | $24.1M | $71.1M | ||
| Q2 24 | $23.5M | $48.5M | ||
| Q1 24 | $25.1M | $51.0M |
总资产KLTRPBYI
| Q4 25 | $164.7M | $216.3M | ||
| Q3 25 | $172.6M | $202.9M | ||
| Q2 25 | $169.4M | $194.9M | ||
| Q1 25 | $172.8M | $196.2M | ||
| Q4 24 | $181.3M | $213.3M | ||
| Q3 24 | $178.6M | $220.7M | ||
| Q2 24 | $171.3M | $205.0M | ||
| Q1 24 | $173.1M | $214.1M |
负债/权益比KLTRPBYI
| Q4 25 | 4.63× | 0.17× | ||
| Q3 25 | 1.73× | 0.30× | ||
| Q2 25 | 1.85× | 0.43× | ||
| Q1 25 | 1.41× | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | 1.38× | 1.12× | ||
| Q2 24 | 1.43× | 1.87× | ||
| Q1 24 | 1.36× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.6M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $3.5M | $14.4M |
| 自由现金流率自由现金流/营收 | 7.7% | 19.1% |
| 资本支出强度资本支出/营收 | 0.3% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $13.9M | $41.7M |
8季度趋势，按日历期对齐
经营现金流KLTRPBYI
| Q4 25 | $3.6M | $14.4M | ||
| Q3 25 | $9.3M | $9.7M | ||
| Q2 25 | $2.7M | $14.1M | ||
| Q1 25 | $-1.0M | $3.6M | ||
| Q4 24 | $4.3M | $15.6M | ||
| Q3 24 | $10.7M | $11.0M | ||
| Q2 24 | $-1.6M | $1.0M | ||
| Q1 24 | $-1.1M | $11.2M |
自由现金流KLTRPBYI
| Q4 25 | $3.5M | $14.4M | ||
| Q3 25 | $9.2M | $9.7M | ||
| Q2 25 | $2.5M | $14.1M | ||
| Q1 25 | $-1.3M | $3.6M | ||
| Q4 24 | $4.2M | $15.6M | ||
| Q3 24 | $10.6M | $11.0M | ||
| Q2 24 | $-1.8M | $1.0M | ||
| Q1 24 | $-1.2M | — |
自由现金流率KLTRPBYI
| Q4 25 | 7.7% | 19.1% | ||
| Q3 25 | 20.9% | 17.7% | ||
| Q2 25 | 5.7% | 26.8% | ||
| Q1 25 | -2.9% | 7.7% | ||
| Q4 24 | 9.2% | 26.4% | ||
| Q3 24 | 23.9% | 13.7% | ||
| Q2 24 | -4.2% | 2.1% | ||
| Q1 24 | -2.8% | — |
资本支出强度KLTRPBYI
| Q4 25 | 0.3% | 0.0% | ||
| Q3 25 | 0.3% | 0.0% | ||
| Q2 25 | 0.3% | 0.0% | ||
| Q1 25 | 0.6% | 0.1% | ||
| Q4 24 | 0.2% | 0.0% | ||
| Q3 24 | 0.2% | 0.0% | ||
| Q2 24 | 0.5% | 0.0% | ||
| Q1 24 | 0.2% | 0.0% |
现金转化率KLTRPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KLTR
| Subscription | $42.7M | 94% |
| Professional Services | $2.9M | 6% |
PBYI
暂无分部数据
